OGEN Stock Analysis: Buy, Sell, or Hold?
OGEN - Oragenics Inc.
$0.53
0.03 (5.86%)
▲
5d:
+5.65%
30d:
-9.52%
90d:
-14.63%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 14, 2026
9d
Get Alerted When OGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OGEN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: OGEN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: OGEN is currently trading at $0.53, which is considered slightly low relative to its 30-day fair value range of $0.51 to $0.59.
Technical Outlook: Technically, OGEN is in a downtrend. Immediate support is located at $0.48, while resistance sits at $0.59. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: OGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+277.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OGEN is in a downtrend. Immediate support is located at $0.48, while resistance sits at $0.59. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: OGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+277.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.51 -
$0.59
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.9%)
- BULLISH: Trading 277.9% below Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$0.51 -
$0.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.48
Resistance Level
$0.59
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.77
Wall Street Target
$2.00
(+277.9%)
Revenue Growth (YoY)
-91.3%
Share & Embed Analysis
Last updated: August 04, 2026 7:12 AM ET
Data refreshes hourly during market hours. Next update: 8:12 AM
Data refreshes hourly during market hours. Next update: 8:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$207 | 58 HOLD |
